Kalia Kumud 4

What Happened

• Kalia Kumud, Chief Information Officer of Guardant Health (GH), had multiple restricted stock unit (RSU) installments convert to common shares on July 1, 2026. A total of 6,046 shares were issued upon vesting (four separate RSU conversions). To cover tax withholding, the company retained (withheld) 3,066 shares at an implied value of $170.77 per share, equal to $523,581. The insider received the remaining 2,980 shares net of withholding.
• These were vesting conversions of RSU awards (no cash purchase: reported exercise/conversion price $0). The withholding is recorded as a "Payment of exercise price or tax liability" (code F), not an open-market sale.

Key Details

• Transaction date: July 1, 2026. Form 4 filed July 2, 2026 (next business day; appears timely).
• Vesting/conversions recorded: 1,607; 1,084; 1,994; and 1,361 shares (total 6,046).
• Tax withholding: 3,066 shares withheld at $170.77/share = $523,581 (footnote F1: shares retained by company to meet tax obligations; amount not in excess of liability).
• Net shares delivered to insider: 2,980 (6,046 vested − 3,066 withheld).
• Related awards/vesting schedules: these conversions relate to RSU grants described in footnotes (grants from Nov 7, 2022; Dec 13, 2023; Nov 8, 2024; Mar 12, 2025) that vest over multi-year schedules (see F2, F4, F5, F6).
• Codes explained: M = exercise/conversion of derivative (RSU conversion); F = tax withholding payment. F3 is not applicable for RSUs per filing.

Context

• This is a routine vesting and tax-withholding event, not an open-market sale or purchase. Vesting/withholding transactions are standard compensation mechanics and do not necessarily signal the insider’s market view.
• For retail investors: purchases or open-market buys are typically more informative about insider sentiment; RSU vesting with share withholding is primarily administrative and tax-related.